171 related articles for article (PubMed ID: 28415818)
1. Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.
Karlsson H; Fryknäs M; Strese S; Gullbo J; Westman G; Bremberg U; Sjöblom T; Pandzic T; Larsson R; Nygren P
Oncotarget; 2017 May; 8(18):30217-30234. PubMed ID: 28415818
[TBL] [Abstract][Full Text] [Related]
2. Calcium release induced by 2-pyridinecarboxaldehyde thiosemicarbazone and its copper complex contributes to tumor cell death.
Fu Y; Liu Y; Wang J; Li C; Zhou S; Yang Y; Zhou P; Lu C; Li C
Oncol Rep; 2017 Mar; 37(3):1662-1670. PubMed ID: 28112358
[TBL] [Abstract][Full Text] [Related]
3. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity.
Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487
[TBL] [Abstract][Full Text] [Related]
4. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
5. Thiosemicarbazone-metal complexes exhibiting cytotoxicity in colon cancer cell lines through oxidative stress.
Alcaraz R; Muñiz P; Cavia M; Palacios Ó; Samper KG; Gil-García R; Jiménez-Pérez A; García-Tojal J; García-Girón C
J Inorg Biochem; 2020 May; 206():110993. PubMed ID: 32088593
[TBL] [Abstract][Full Text] [Related]
6. Increased generation of intracellular reactive oxygen species initiates selective cytotoxicity against the MCF-7 cell line resultant from redox active combination therapy using copper-thiosemicarbazone complexes.
Akladios FN; Andrew SD; Parkinson CJ
J Biol Inorg Chem; 2016 Jun; 21(3):407-19. PubMed ID: 26951232
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
[TBL] [Abstract][Full Text] [Related]
8. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.
Deng J; Yu P; Zhang Z; Wang J; Cai J; Wu N; Sun H; Liang H; Yang F
Eur J Med Chem; 2018 Oct; 158():442-452. PubMed ID: 30241011
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of apoptosis induction in K562 and KG1a leukemia cells by a water-soluble copper(II) thiosemicarbazone complex.
Parsa FG; Feizi MAH; Safaralizadeh R; Hosseini-Yazdi SA; Mahdavi M
J Biol Inorg Chem; 2020 May; 25(3):383-394. PubMed ID: 32274578
[TBL] [Abstract][Full Text] [Related]
10. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
[TBL] [Abstract][Full Text] [Related]
11. Influence of Complexation of Thiosemicarbazone Derivatives with Cu (II) Ions on Their Antitumor Activity against Melanoma Cells.
Pitucha M; Korga-Plewko A; Czylkowska A; Rogalewicz B; Drozd M; Iwan M; Kubik J; Humeniuk E; Adamczuk G; Karczmarzyk Z; Fornal E; Wysocki W; Bartnik P
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803618
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines.
Easmon J; Pürstinger G; Heinisch G; Roth T; Fiebig HH; Holzer W; Jäger W; Jenny M; Hofmann J
J Med Chem; 2001 Jun; 44(13):2164-71. PubMed ID: 11405653
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of thiophene-thiosemicarbazone derivatives and evaluation of their in vitro and in vivo antitumor activities.
de Oliveira JF; da Silva AL; Vendramini-Costa DB; da Cruz Amorim CA; Campos JF; Ribeiro AG; Olímpio de Moura R; Neves JL; Ruiz AL; Ernesto de Carvalho J; Alves de Lima Mdo C
Eur J Med Chem; 2015 Nov; 104():148-56. PubMed ID: 26454648
[TBL] [Abstract][Full Text] [Related]
14. Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.
Lovejoy DB; Sharp DM; Seebacher N; Obeidy P; Prichard T; Stefani C; Basha MT; Sharpe PC; Jansson PJ; Kalinowski DS; Bernhardt PV; Richardson DR
J Med Chem; 2012 Aug; 55(16):7230-44. PubMed ID: 22861499
[TBL] [Abstract][Full Text] [Related]
15. Thiosemicarbazone Derivative Induces in vitro Apoptosis in Metastatic PC-3 Cells via Activation of Mitochondrial Pathway.
Sinniah SK; Tan KW; Ng SW; Sim KS
Anticancer Agents Med Chem; 2017; 17(5):741-753. PubMed ID: 27671302
[TBL] [Abstract][Full Text] [Related]
16. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
[TBL] [Abstract][Full Text] [Related]
17. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity.
Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV
J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562
[TBL] [Abstract][Full Text] [Related]
18. Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention.
Kowol CR; Miklos W; Pfaff S; Hager S; Kallus S; Pelivan K; Kubanik M; Enyedy ÉA; Berger W; Heffeter P; Keppler BK
J Med Chem; 2016 Jul; 59(14):6739-52. PubMed ID: 27336684
[TBL] [Abstract][Full Text] [Related]
19. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells.
Altintop MD; Sever B; Özdemir A; Kuş G; Oztopcu-Vatan P; Kabadere S; Kaplancikli ZA
J Enzyme Inhib Med Chem; 2016; 31(3):410-6. PubMed ID: 25826149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]